In addition, single nucleotide polymorphisms in the IL-6 promoter region can transcribe and regulate the expression of IL-6, and populations with special IL-6 gene polymorphism exhibit a higher risk of Group 1 PAH and a more severe phenotype. This evidence concerns the gene IL6 and pulmonary arterial hypertension.